Evidence map›Paper›PMID 23394493›Full record

Trial reportRedox report : communications in free radical research2013

Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation.

Takako Miyamae, Manabu Seki, Tomoko Naga, Shinya Uchino, Haruki Asazuma, Takuma Yoshida, Yuki Iizuka, Masako Kikuchi, Tomoyuki Imagawa, Yutaka Natsumeda and 2 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Redox report : communications in free radical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05871086 (The Effect of Coenzyme Q10 Supplementation on the Clinical Outcome of Juvenile Idiopathic Arthritis Patients), which is not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05871086 phase2 / phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effect of Coenzyme Q10 Supplementation on the Clinical Outcome of Juvenile Idiopathic Arthritis Patients

TypeinterventionalSponsorNourhan ElsherifRan2023 to 2023Enrolled60ConditionsJuvenile Idiopathic ArthritisArmsCoenzyme Q10, Placebo, Standard Regimen
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of Coenzyme QCNS neuroscience & therapeutics · 2017
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Coenzyme Q10 and Autoimmune Disorders: An Overview.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. The Use of the Coenzyme QAntioxidants (Basel, Switzerland) · 2022
    Review
  14. Review
  15. Efficacy and safety of fermentedFrontiers in nutrition · 2022
    Article
  16. Article
  17. Coenzyme QNutrients · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Takako MiyamaeDepartment of Pediatrics, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
Manabu Seki
Tomoko Naga
Shinya Uchino
Haruki Asazuma
Takuma Yoshida
Yuki Iizuka
Masako Kikuchi
Tomoyuki Imagawa
Yutaka Natsumeda
Shumpei Yokota
Yorihiro Yamamoto
Yokohama City University · JPTokyo University of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibromyalgia (FM) is characterized by generalized pain and chronic fatigue of unknown etiology. To evaluate the role of oxidative stress in this disorder, we measured plasma levels of ubiquinone-10, ubiquinol-10, free cholesterol (FC), cholesterol esters (CE), and free fatty acids (FFA) in patients with juvenile FM (n=10) and in healthy control subjects (n=67). Levels of FC and CE were significantly increased in juvenile FM as compared with controls, suggesting the presence of hypercholesterolemia in this disease. However, plasma level of ubiquinol-10 was significantly decreased and the ratio of ubiquinone-10 to total coenzyme Q10 (%CoQ10) was significantly increased in juvenile FM relative to healthy controls, suggesting that FM is associated with coenzyme Q10 deficiency and increased oxidative stress. Moreover, plasma level of FFA was significantly higher and the content of polyunsaturated fatty acids (PUFA) in total FFA was significantly lower in FM than in controls, suggesting increased tissue oxidative damage in juvenile FM. Interestingly, the content of monoenoic acids, such as oleic and palmitoleic acids, was significantly increased in FM relative to controls, probably to compensate for the loss of PUFA. Next, we examined the effect of ubiquinol-10 supplementation (100 mg/day for 12 weeks) in FM patients. This resulted in an increase in coenzyme Q10 levels and a decrease in %CoQ10. No changes were observed in FFA levels or their composition. However, plasma levels of FC and CE significantly decreased and the ratio of FC to CE also significantly decreased, suggesting that ubiquinol-10 supplementation improved cholesterol metabolism. Ubiquinol-10 supplementation also improved chronic fatigue scores as measured by the Chalder Fatigue Scale.

Indexed as

Oxidative StressAdolescentAntioxidantsAtaxiaCase-Control StudiesChildCholesterolDietary SupplementsDouble-Blind MethodFatigueFatty Acids, MonounsaturatedFatty Acids, NonesterifiedFemaleFibromyalgiaHumansHypercholesterolemiaAntioxidantsCholesterolcoenzyme Q10Fatty Acids, MonounsaturatedFatty Acids, NonesterifiedOleic Acidpalmitoleic acidubiquinol-10Ubiquinone

Identifiers

PMID23394493
PMCPMC6837523
OpenAlexW2048855274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.